These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1131805)

  • 1. General discussion: treatment of prostatic cancer.
    Cancer Chemother Rep; 1975; 59(1):251-4. PubMed ID: 1131805
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of prostate cancer].
    Imre R
    Orv Hetil; 2005 Aug; 146(35):1839-42. PubMed ID: 16187544
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prostatic cancer, diagnosis and hormonal treatment (author's transl)].
    Rutishauser G
    Schweiz Rundsch Med Prax; 1974 Feb; 63(5):120-3. PubMed ID: 4424280
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant systemic therapy of prostate cancer.
    Raghavan D
    Semin Oncol; 1995 Dec; 22(6):633-40. PubMed ID: 8539638
    [No Abstract]   [Full Text] [Related]  

  • 5. [The immunotherapy of prostatic cancer].
    Murav'ev VB; Al'tvaĭn IE
    Urol Nefrol (Mosk); 1997; (4):46-8. PubMed ID: 9381625
    [No Abstract]   [Full Text] [Related]  

  • 6. Carcinoma of the prostate: a review. II. Treatment according to clinical stage of the cancer.
    Blackard CE
    J Lancet; 1968 Jan; 88(1):5-15. PubMed ID: 4865761
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of cancer of the prostate].
    Arvis G
    Sem Hop Ther; 1977 Apr; 53(4):255-7. PubMed ID: 882872
    [No Abstract]   [Full Text] [Related]  

  • 8. [Heterotransplantation of human malignant urogenital tumors. 1. Serial transplantation and evaluation of the sensitivity of prostatic carcinoma to various treatments in nude mice (author's transl)].
    Yui Y
    Nihon Hinyokika Gakkai Zasshi; 1979 Jan; 70(1):28-45. PubMed ID: 430919
    [No Abstract]   [Full Text] [Related]  

  • 9. Androgen depletion/repletion in combination with chemotherapy: strategy for secondary treatment of metastatic prostatic cancer.
    Santen RJ; English H; Rohner T; Drago J; Lipton A; Harvey H; Simmonds M; Boucher A; Glode LM; Wettlaufer J
    Prog Clin Biol Res; 1985; 185A():359-71. PubMed ID: 4034580
    [No Abstract]   [Full Text] [Related]  

  • 10. [What is certain in therapy of prostatic adenoma and prostatic carcinoma?].
    Klosterhalfen H
    Internist (Berl); 1977 Dec; 18(12):642-9. PubMed ID: 74367
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of estrogen-resistant forms of cancer of the prostate].
    Marinbakh EB; Ar'e VM
    Urol Nefrol (Mosk); 1974; 39(4):68-74. PubMed ID: 4606039
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of chemotherapy in the treatment of prostatic carcinoma.
    Tonato M; Bracarda S
    Rays; 1993; 18(1):87-93. PubMed ID: 8356244
    [No Abstract]   [Full Text] [Related]  

  • 13. Selecting early therapy in prostate cancer.
    Petrylak D
    Clin Adv Hematol Oncol; 2015 Feb; 13(2):124-5. PubMed ID: 25774482
    [No Abstract]   [Full Text] [Related]  

  • 14. Emerging drugs for prostate cancer.
    Siddiqui K; Klotz LH
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):455-70. PubMed ID: 19650748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decapeptyl in the treatment of advanced prostatic cancer: comparative study with pulpectomy.
    Botto H; Richard F; Mathieu F; Camey M
    Prog Clin Biol Res; 1989; 303():53-60. PubMed ID: 2528740
    [No Abstract]   [Full Text] [Related]  

  • 16. The Scandinavian Prostatic Cancer Group.
    Høisaeter PA; Rasmussen F
    Scand J Clin Lab Invest Suppl; 1985; 179():7-11. PubMed ID: 2934797
    [No Abstract]   [Full Text] [Related]  

  • 17. [Surgical and hormonal therapy of prostatic carcinoma].
    Frick J
    Wien Med Wochenschr; 1977 Aug; 127(15):480-2. PubMed ID: 906541
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of cancer of the prostate.
    Catalona WJ
    N Engl J Med; 1994 Oct; 331(15):996-1004. PubMed ID: 7880240
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapy: a new paradigm for androgen-refractory prostate cancer.
    Loughlin KR
    Urol Oncol; 2008; 26(6):575. PubMed ID: 18996313
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hormonal, radiation and combined therapy of locally advanced prostatic cancer (T3NXM0)].
    Pavlov AS; Loran OB; Simakina EP; Tomkevich BA; Repina AG; Gribova RG
    Urologiia; 2005; (4):24-6. PubMed ID: 16158741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.